Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
about
Effect of diet or diet plus physical activity versus usual care on inflammatory markers in patients with newly diagnosed type 2 diabetes: the Early ACTivity in Diabetes (ACTID) randomized, controlled trial.Traffic exposure in a population with high prevalence type 2 diabetes--do medications influence concentrations of C-reactive protein?Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients--a randomized crossover trial.Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function.Systemic inflammation (C-reactive protein) in type 2 diabetic patients is associated with ambient air pollution in Pune City, India.Nonobese, exercising children diagnosed with dyslipidemia have normal C-reactive proteinSignificance of inflammatory markers in diabetic patients with stable coronary artery disease.Prognostic Importance of C-Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study.Quo vadis: what is the future of periodontics? How will we get there?Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans.Relationship of high-sensitive C-reactive protein with cardiovascular risk factors, clinical presentation and angiographic profile in patients with acute coronary syndrome: an Indian perspectiveEffect of pioglitazone versus metformin on cardiovascular risk markers in type 2 diabetes.
P2860
Q35021892-2EB70183-435F-4D87-9124-40E50C9FFEA3Q36141065-469BCA15-B9CF-41CA-AE35-28B06A065476Q36474275-ED535176-D6CA-4D32-9518-893D2524BDCAQ36512836-E750A6EA-3B60-4ECD-AD1E-53CAFC9E8387Q36629446-3E87CA74-C2DE-4159-9E3A-EFC07EFD323CQ37167589-72F9D7D6-F4FF-4FF2-817E-18C8D3B60D34Q37320947-D52F438B-6B4F-4AFF-98AD-F6EF3E307D51Q37556069-5B02630B-8A19-4B39-9C09-B2717C70EE2FQ38649504-E9387B4A-88C1-49C6-994D-36D0EED39515Q40538325-AAE0A03E-6342-4812-8BAA-9C44F339B004Q42805798-5B5E4ABB-16DF-4AA2-BFC5-F5C02352BE3BQ51345495-85C2BE43-756E-4D7E-9C4B-EFCE31F757B9
P2860
Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
@en
Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
@nl
type
label
Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
@en
Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
@nl
prefLabel
Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
@en
Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
@nl
P356
P1476
Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.
@en
P2093
Paresh Dandona
P304
P356
10.4065/83.3.333
P407
P577
2008-03-01T00:00:00Z